Clinical Trial

Prospective Twin Pregnancy Cohort at Montpellier University Hospital

Study acronym: COGEM
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational cohort study aims to investigate the impact of the maternal and early-life exposome on neonatal and early childhood health outcomes in twin pregnancies followed at University Hospital of Montpellier (France). Grounded in the Developmental Origins of Health and Disease (DOHaD) framework, the study focuses on how environmental, biological, and lifestyle exposures during pregnancy and the first year of life influence fetal growth, neonatal health, and early development. A total of 120 women with monochorionic or dichorionic twin pregnancies and their 240 children will be included. Maternal exposome assessment includes air pollution exposure, lifestyle, diet, medical history, and biological measurements. Neonatal outcomes, including abnormal birth weight, will be evaluated at birth, and children will be followed until one year of age to assess growth, health events, and developmental outcomes. Biological samples collected at different times during the study will allow the assessment of chemical exposures and epigenetic markers. This study aims to generate original French twin pregnancy data and to improve understanding of environmental determinants of early-life health.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2029-03-01 -> 2030-03-01 2026-06-19
minor Completion pushed: 2029-03-01 -> 2030-12-01 2026-06-19
Trial Details
NCT Number NCT07408973
Lead Sponsor University Hospital, Montpellier
Collaborators: Institut National de la Santé Et de la Recherche Médicale, France
Conditions Pregnancy, Twin
Enrollment 360 participants
Start Date 2026-12
Primary Completion 2030-03-01 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-18